Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Byrd

Showing results (211-220 of 1,058) with videos related to

Pageof 106
Sort By:
Chest|September 13, 2002
Fludarabine-related pulmonary toxicity: a distinct clinical entity in chronic lymphoproliferative syndromesDonald L Helman, John C Byrd, Noel C Ales, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|February 24, 2001
Reliability of an instrument for evaluating antimicrobial appropriateness in hospitalized patientsC T Taylor, L M Stewart, D C Byrd, et al.
Cancer|April 5, 2002
Frequency and type of serious infections in fludarabine-refractory B-cell chronic lymphocytic leukemia and small lymphocytic lymphoma: implications for clinical trials in this patient populationJeremy G Perkins, Joseph M Flynn, Robin S Howard, et al.
Hospital Pharmacy|December 6, 2014
Interstitial pneumonitis from treatment with gemcitabineBrolin B Poole, Leslie A Hamilton, Megan M Brockman, et al.
Vox Sanguinis|March 21, 1998
Mixed-type autoimmune hemolytic anemia following fludarabine treatment in a patient with chronic lymphocytic leukemia/small cell lymphomaD J Vick, J C Byrd, C L Beal, et al.
Cancer Biotherapy & Radiopharmaceuticals|November 6, 2007
Community-based phase II trial of PCR for CLL/SLL patientsNeil E Kay, Tait D Shanafelt, John C Byrd, et al.
The American Review of Respiratory Disease|September 11, 1991
The structure of human intestinal apomucinsY S Kim, J R Gum, J C Byrd, et al.
RSC Advances|April 28, 2022
3-Methyl-1,2,3-triazolium-1<i>N</i>-dinitromethylylide and the strategy of zwitterionic dinitromethyl groups in energetic materials designDominique R Wozniak, Matthias Zeller, Edward F C Byrd, et al.
Cancer Research|November 1, 1987
Characterization of quantitative mucin variants from a human colon cancer cell lineS F Kuan, J C Byrd, C B Basbaum, et al.
Pharmacotherapy|December 22, 1999
Vitamin K to reverse excessive anticoagulation: a review of the literatureC T Taylor, E A Chester, D C Byrd, et al.
Pageof 106

Showing results (211-220 of 1,058) with videos related to

Sort By:
Pageof 106
Chest|September 13, 2002
Fludarabine-related pulmonary toxicity: a distinct clinical entity in chronic lymphoproliferative syndromesDonald L Helman, John C Byrd, Noel C Ales, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|February 24, 2001
Reliability of an instrument for evaluating antimicrobial appropriateness in hospitalized patientsC T Taylor, L M Stewart, D C Byrd, et al.
Cancer|April 5, 2002
Frequency and type of serious infections in fludarabine-refractory B-cell chronic lymphocytic leukemia and small lymphocytic lymphoma: implications for clinical trials in this patient populationJeremy G Perkins, Joseph M Flynn, Robin S Howard, et al.
Hospital Pharmacy|December 6, 2014
Interstitial pneumonitis from treatment with gemcitabineBrolin B Poole, Leslie A Hamilton, Megan M Brockman, et al.
Vox Sanguinis|March 21, 1998
Mixed-type autoimmune hemolytic anemia following fludarabine treatment in a patient with chronic lymphocytic leukemia/small cell lymphomaD J Vick, J C Byrd, C L Beal, et al.
Cancer Biotherapy & Radiopharmaceuticals|November 6, 2007
Community-based phase II trial of PCR for CLL/SLL patientsNeil E Kay, Tait D Shanafelt, John C Byrd, et al.
The American Review of Respiratory Disease|September 11, 1991
The structure of human intestinal apomucinsY S Kim, J R Gum, J C Byrd, et al.
RSC Advances|April 28, 2022
3-Methyl-1,2,3-triazolium-1<i>N</i>-dinitromethylylide and the strategy of zwitterionic dinitromethyl groups in energetic materials designDominique R Wozniak, Matthias Zeller, Edward F C Byrd, et al.
Cancer Research|November 1, 1987
Characterization of quantitative mucin variants from a human colon cancer cell lineS F Kuan, J C Byrd, C B Basbaum, et al.
Pharmacotherapy|December 22, 1999
Vitamin K to reverse excessive anticoagulation: a review of the literatureC T Taylor, E A Chester, D C Byrd, et al.
Pageof 106